This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pivonello, R. Articles by Colao, A. Search for Related Content PubMed PubMed Citation Articles by Pivonello, R. Articles by Colao, A.

Effect of a Short-Term Treatment with Alendronate on Bone Density and Bone Markers in Patients with Central Diabetes Insipidus

Department of Molecular and Clinical Endocrinology and Oncology (R.P., A.F., C.D.S., M.F., G.L., A.C.) and CNR, Biomorphological and Functional Sciences (M.K., M.S.), Federico II University, 80131 Naples, Italy

Address all correspondence and requests for reprints to: Annamaria Colao M.D., Ph.D., Department of Molecular and Clinical Endocrinology and Oncology, Federico II University of Naples, Via Sergio Pansini 5, 80131, Naples, Italy. E-mail: colao{at}unina.it

The aim of this open prospective randomized study was to evaluate the effect of a 6-month treatment with alendronate on the bone mineral density (BMD) at lumbar spine in patients with central diabetes insipidus. Eighteen patients with central diabetes insipidus and 18 sex- and age-matched healthy subjects entered this study. At study entry, all subjects underwent BMD assessment at the lumbar spine and measurement of serum osteocalcin (OC) and cross-linked N-telopeptides of type I collagen (Ntx). Thereafter, 9 of the 18 patients were randomized to receive treatment with alendronate at a dose of 10 mg, orally, once daily for 6 months (group 1), whereas the remaining 9 patients did not receive any treatment affecting bone status during this period (group 2). After 6 months, bone metabolism and bone density study were repeated in all patients.

At baseline, lumbar BMD values (0.86 ± 0.03 vs. 1.01 ± 0.02 g/cm₂; P < 0.001) and serum OC levels (4.7 ± 0.3 vs. 7.9 ± 0.2 µg/L; P < 0.001) were significantly lower, whereas urinary Ntx levels were significantly higher [72.0 ± 1.9 vs. 64.6 ± 1.7 nmol bone collagen equivalents (BCE)/nmol creatinine (Cr); P < 0.01] in patients than in controls. After randomization, no difference in lumbar BMD, serum OC, or urinary Ntx was found between patients of group 1 and group 2. At the 6 month follow-up, no difference in serum OC levels was found compared to baseline evaluation in patients of both group 1 and group 2. By contrast, a significant decrease in urinary Ntx levels was found in patients of group 1 (70.3 ± 3.0 vs. 75.4 ± 2.1 nmol BCE/nmol Cr; P < 0.05), but not in patients of group 2 (68.8 ± 3.3 vs. 68.5 ± 3.0 nmol BCE/nmol Cr; P = NS). A significant increase in lumbar BMD values was found in patients of group 1 (0.88 ± 0.04 vs. 0.83 ± 0.04 g/cm²; P < 0.05), whereas a significant decrease in lumbar BMD values was found in patients of group 2 (0.86 ± 0.05 vs. 0.89 ± 0.05 g/cm²; P < 0.05). Lumbar BMD increased 7.0 ± 1.5% in patients of group 1 and decreased 4.2 ± 1.8% in patients of group 2 (P < 0.001).

In conclusion, this study demonstrated that a 6-month treatment with alendronate in patients with central diabetes insipidus was effective in significantly improving BMD at the lumbar spine, which was significantly worsened in untreated patients. Therefore, alendronate treatment could be used in patients with central diabetes insipidus with documented osteopenia or osteoporosis.

This article has been cited by other articles:

				J. P. Brown and R. G. Josse Lignes directrices de pratique clinique 2002 pour le diagnostic et le traitement de l'osteoporose au Canada Can. Med. Assoc. J., March 18, 2003; 168(90060): SF1 - 38. [Abstract] [Full Text] [PDF]

				J. P. Brown and R. G. Josse 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada Can. Med. Assoc. J., November 12, 2002; 167(90100): s1 - 34. [Abstract] [Full Text] [PDF]